Polymer Drugs in the Clinical Stage Advantages and Prospects /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Maeda, Hiroshi (Επιμελητής έκδοσης), Kabanov, Alexander (Επιμελητής έκδοσης), Kataoka, Kazunori (Επιμελητής έκδοσης), Okano, Teruo (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Boston, MA : Springer US, 2003.
• Σειρά: Advances in Experimental Medicine and Biology, 519
• Θέματα: Medicine.; Pharmacy.; Pharmacology.; Polymers.; Oncology.; Medical biochemistry.; Biomedicine.; Pharmacology/Toxicology.; Polymer Sciences.; Medical Biochemistry.

Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of thi...

Πίνακας περιεχομένων:

• Challenges in Polymer Therapeutics
• Factors and Mechanism of “EPR” Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS
• PEG-Adenosine Deaminase and PEG-Asparaginase
• Peginterferon alfa-2a (40KD): A Potent Long-Acting Form of Interferon alfa-2a for the Treatment of Hepatitis C
• PEG-Methioninase
• Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate
• HPMA Copolymer Delivery of Chemotherapy and Photodynamic Therapy in Ovarian Cancer
• Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer
• CM-Dextran-Polyalcohol-Camptothecin Conjugate
• Polymeric Micelle Drug Carrier Systems: PEG-PAsp(Dox) and Second Generation of Micellar Drugs
• An Interim Analysis of Phase I Clinical Trial of MCC-465, a Doxorubicin (DXR) Encapsulated in PEG-immunoliposome, in Patients with Metastatic Stomach Cancer
• Polymer Conjugates for Imaging
• S-Nitrosylated Polyethylene Glycol-conjugated Hemoglobin Derivative as a Candidate Material for Oxygen Therapeutics.